A 63-year-old woman with long-standing type 2 diabetes (HbA1c 8.5%), hypertension and a prior NSTEMI is on maximal metformin and an ACE inhibitor. eGF...

Question

A 63-year-old woman with long-standing type 2 diabetes (HbA1c 8.5%), hypertension and a prior NSTEMI is on maximal metformin and an ACE inhibitor. eGFR is 55 mL/min/1.73 m² and urinary albumin-to-creatinine ratio is 12 mg/mmol. According to Diabetes Canada, which additional antihyperglycaemic agent is preferred to reduce her cardiovascular risk?

Accepted Answer

SGLT2 inhibitor (e.g., empagliflozin)

Answer

Basal insulin

Answer

Sulfonylurea (e.g., gliclazide)

Answer

DPP-4 inhibitor (e.g., sitagliptin)

Answer

Thiazolidinedione (e.g., pioglitazone)

ca-mccqe1 MCQ (SBA): Type 2 diabetes mellitus with ASCVD